Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Pharmstandard International S.A. Create: Alert

All | News | Filings
Date FiledTypeDescription
11/15/2018 SC 13G Pharmstandard International S.A. reports a 4.2% stake in Allena Pharmaceuticals, Inc.
11/15/2018 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/14/2018 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/15/2018 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/20/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G Pharmstandard International S.A. reports a 5% stake in Allena Pharmaceuticals, Inc.
02/14/2018 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/02/2017 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/02/2017 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Disposed of 99,495 shares @ $795.96, valued at $79.2M
08/16/2017 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
08/15/2017 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
06/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/23/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/11/2017 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings
02/13/2017 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings
02/13/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
10/18/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
10/13/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/04/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/30/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 28,518 shares @ $4.54, valued at $129.5k
Bought 15,100 shares @ $4.6, valued at $69.5k
09/21/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 5,580 shares @ $4.76, valued at $26.6k
Bought 41,259 shares @ $4.77, valued at $196.8k
09/20/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 15,880 shares @ $4.76, valued at $75.6k
Bought 36,632 shares @ $4.78, valued at $175.1k
09/07/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 16,977 shares @ $4.78, valued at $81.2k
08/29/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 55,224 shares @ $4.57, valued at $252.4k
08/25/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 9,599 shares @ $4.36, valued at $41.9k
Bought 57,772 shares @ $4.55, valued at $262.9k
08/23/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 53,524 shares @ $4.23, valued at $226.4k
Bought 21,950 shares @ $4.26, valued at $93.5k
08/18/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
08/04/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 2,363,636 shares @ $0
Bought 1,772,727 options to buy @ $5.5, valued at $9.7M
07/12/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
07/01/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 2,678,301 shares @ $0
Bought 2,008,726 options to buy @ $5.35, valued at $10.7M
05/27/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
03/22/2016 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership
03/16/2016 4 Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns: Bought 1,785,534 shares @ $0
Bought 1,339,151 options to buy @ $5.35, valued at $7.2M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy